Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 3, 2004 - Issue 3
Submit an article Journal homepage
64
Views
5
CrossRef citations to date
0
Altmetric
Review

Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection

Jason E Stout Division of Infectious Diseases, Department of Medicine, Box 3306, Duke University Medical Center, Durham, NC 27710, USA. [email protected]
Pages 187-198 | Published online: 03 Mar 2005

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sadhna Sharma & Amandeep Singh. (2011) Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications. Expert Opinion on Investigational Drugs 20:12, pages 1665-1676.
Read now

Articles from other publishers (4)

Zahir Hussain, Junjie Zhu & Xiaochao Ma. (2021) Metabolism and Hepatotoxicity of Pyrazinamide, an Antituberculosis Drug. Drug Metabolism and Disposition 49:8, pages 679-682.
Crossref
Jonathan G. Stine & James H. Lewis. (2013) Hepatotoxicity of Antibiotics. Clinics in Liver Disease 17:4, pages 609-642.
Crossref
Robert S Wallis. (2008) Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. The Lancet Infectious Diseases 8:10, pages 601-611.
Crossref
C. Becker, J.B. Dressman, G.L. Amidon, H.E. Junginger, S. Kopp, K.K. Midha, V.P. Shah, S. Stavchansky & D.M. Barends. (2008) Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Pyrazinamide**A project of the International Pharmaceutical Federation FIP, Groupe BCS, www.fip.org/bcs.**This article reflects the scientific opinion of the authors and not the policies of regulating agencies.. Journal of Pharmaceutical Sciences 97:9, pages 3709-3720.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.